I am/have/had
I am looking for
Advanced Filters
Found 246 clinical trials
Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.
Efficacy and Safety of Locoregional treatments Combined With PD-1 Inhibitor in Patients With Unresectable Hepatocellular Carcinoma.
unresectable hepatocellular carcinoma
pd-1 inhibitor
hepatocellular carcinoma
TACE
carcinoma
- 0 views
- 16 Feb, 2024
- 1 location
Preliminary Antitumor Activity Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma
The primary objective of this study is to assess the preliminary antitumor activity as indicated by overall response rate (ORR) of tislelizumab in combination with lenvatinib in participants with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).
metastatic hepatocellular carcinoma
liver cancer
hepatocellular carcinoma
lenvatinib
unresectable hepatocellular carcinoma
- 0 views
- 05 Aug, 2020